3 Development of OctiPAT: a patient-facing mobile and web-based application to provide higher quality, patient-focused, multidisciplinary care to a complex patient cohort

Author(s):  
Natalie Yerlett ◽  
Hsin-Chin Shen ◽  
Zhongjie Ma ◽  
Ling Qin ◽  
Anna Martinez ◽  
...  
2019 ◽  
Vol 26 (2) ◽  
pp. 199-212 ◽  
Author(s):  
Ehrin J. Armstrong ◽  
Syed Alam ◽  
Steve Henao ◽  
Arthur C. Lee ◽  
Brian G. DeRubertis ◽  
...  

Critical limb ischemia (CLI), defined as ischemic rest pain or nonhealing ulceration due to arterial insufficiency, represents the most severe and limb-threatening manifestation of peripheral artery disease. A major challenge in the optimal treatment of CLI is that multiple specialties participate in the care of this complex patient population. As a result, the care of patients with CLI is often fragmented, and multidisciplinary societal guidelines have not focused specifically on the care of patients with CLI. Furthermore, multidisciplinary care has the potential to improve patient outcomes, as no single medical specialty addresses all the facets of care necessary to reduce cardiovascular and limb-related morbidity in this complex patient population. This review identifies current gaps in the multidisciplinary care of patients with CLI, with a goal toward increasing disease recognition and timely referral, defining important components of CLI treatment teams, establishing options for revascularization strategies, and identifying best practices for wound care post-revascularization.


2019 ◽  
Vol 72 (4) ◽  
Author(s):  
Amanda Burns ◽  
Leslie Manuel ◽  
Andrew Dickie ◽  
Jennifer Bessey

ABSTRACTBackground: The rate of potential adverse drug events is reported to be 3 times higher among pediatric inpatients than among their adult counterparts. Various methods have been suggested to reduce medication errors in pediatric patients. One of the most influential of these strategies is inclusion of a clinical pharmacist on the multidisciplinary care team. However, there is currently no literature describing the inventory of pharmacy services provided to pediatric patients in Canadian adult hospitals.Objectives: The primary objective of this study was to describe pediatric and neonatal pharmacy services provided in adult hospitals in Canada. The secondary objective was to determine whether the services provided correspond to services that pharmacists working in Canadian pediatric hospitals identified as important for adult hospitals that provide pediatric services.Methods: Two web-based surveys were created, focusing on 35 pharmacy services. The first survey was intended for adult hospitals, and the second for pediatric hospitals. The surveys were distributed by e-mail and were completed in January and February 2018.Results: A total of 55 and 43 valid responses were received from respon-dents in adult hospitals and pediatric hospitals, respectively. An inventory of pharmacy services provided by adult hospitals to their pediatric and neonatal patients was obtained. Of the adult hospitals that responded, 61% (33/54) had pharmacists assigned to pediatric or neonatal units. The frequency with which most pharmacy services were provided was comparable to the importance identified by pharmacists working in pediatric hospitals. However, for the provision of education during admission and at discharge and for the provision of medication reconcil-iation at discharge, frequency and importance were not comparable. Conclusions: Adult hospitals with a pharmacist assigned to an inpatient pediatric or neonatal clinical area met most expectations of pharmacists working in pediatric hospitals in terms of pharmacy services provided. However, some services require optimization for this patient population.RÉSUMÉContexte : On rapporte que le taux de réactions indésirables potentielles aux médicaments est trois fois plus élevé chez les enfants hospitalisés que chez les adultes. Diverses méthodes ont été proposées pour réduire les erreurs de médication chez les patients pédiatriques. L’une des stratégies les plus influentes consiste à inclure un pharmacien clinique au sein de l’équipe de soins pluridisciplinaire. Cependant, il n’existe actuellement aucun document dressant l’inventaire des services de pharmacie offerts aux patients pédiatriques dans les hôpitaux canadiens pour adultes. Objectifs : L’objectif principal de cette étude consistait à décrire les services de pharmacie pédiatriques et néonataux offerts dans les hôpitaux pour adultes au Canada. L’objectif secondaire consistait quant à lui à déterminer si les services offerts à la population pédiatrique dans les hôpitaux pour adultes correspondaient à ceux que les pharmaciens travaillant dans les hôpitaux pédiatriques canadiens reconnaissaient comme étant importants.Méthodes : Deux sondages en ligne se focalisant sur 35 services de pharmacie ont été créés. Le premier était destiné aux hôpitaux pour adultes et le deuxième aux hôpitaux pédiatriques. Les sondages ont été distribués par courriel et effectués en janvier et février 2018.Résultats : Cinquante-cinq (55) répondants des hôpitaux pour adultes et 43 des hôpitaux pédiatriques y ont répondu en bonne et due forme. Les investigateurs ont obtenu en outre la liste des services de pharmacie offerts par les hôpitaux pour adultes à leurs patients pédiatriques et néonataux. Soixante et un pour cent (61 %), soit 33 sur 54, des répondants provenant des hôpitaux pour adultes à étaient des pharmaciens affectés aux unités pédiatriques ou néonatales. La fréquence de l’offre de la majorité des services de pharmacie était d’importance comparable à ce que les pharmaciens travaillant dans les hôpitaux pédiatriques ont relevé. Toutefois, pour ce qui est des instructions données au patient à l’admission et au congé et de la prestation du bilan des médicaments au congé, la fréquence et l’importance de ces services n’étaient pas comparables.Conclusions : Les hôpitaux pour adultes disposant d’un pharmacien affecté à un domaine clinique pédiatrique ou néonatal répondaient à la plupart des attentes des pharmaciens travaillant dans les hôpitaux pédiatriques en termes d’offre de services de pharmacie. Cependant, certains services demandent à être optimisés pour cette population de patients. 


2013 ◽  
Vol 1 (1) ◽  
pp. 24-27 ◽  
Author(s):  
Liesbeth Schrijvers ◽  
Martin Bedford ◽  
Petra Elfvinge ◽  
Karin Andritschke ◽  
Bert Leenders ◽  
...  

Abstract Background: A broad scoping exercise was undertaken to assess and quantify haemophilia nursing care in Europe. Methods: A web-based survey in English was sent to known networks of haemophilia nurses working in Europe. This survey included questions concerning the haemophilia treatment centre, educational level, work activities, gaining knowledge/ expertise and development in the future. Results: In total, 94 nurses in 14 countries in Europe completed the survey. Overall, the majority (62%) of the nurses had over 20 years’ nursing experience, with 44% having more than 10 years’ experience in haemophilia. The educational level varied; with highest educational level of attainment being 41% at nondegree level nursing entry qualification, 35% BSc and 24% MSc. 21% worked in a centre where they treat only children, 26% only adults and 53% both. All had good access to treatment. The core activities (rated >80%) of a haemophilia nurse were: prepare and administer medication, venepuncture and CVADuse (except cannulation), providing education and telephone advice, coordination of (multidisciplinary) care and assistance with clinical trials. Furthermore, 35% stated that they initiated and performed nurse-led research. In the future, almost all nurses would like to develop their expertise and knowledge base by studying at Masters level and above, to have more responsibility, and to conduct research. Conclusion: This scoping exercise provides a baseline assessment of haemophilia nursing across Europe. The results may provide a basis for a more thorough investigation of the current role and the principles of haemophilia nursing care; future opportunities, and the training requirements to develop the specialty.


2020 ◽  
Vol 4 (7) ◽  
pp. 105-111
Author(s):  
Irony A ◽  
Abu Hussain H ◽  
Nigel Y ◽  
Landau T ◽  
Asch N

2016 ◽  
pp. 243 ◽  
Author(s):  
Peter Joseph Jongen ◽  
Ludovicus Sinnige ◽  
Björn van Geel ◽  
Freek Verheul ◽  
Wim Verhagen ◽  
...  

1998 ◽  
Vol 62 (9) ◽  
pp. 671-674
Author(s):  
JF Chaves ◽  
JA Chaves ◽  
MS Lantz
Keyword(s):  

2013 ◽  
Vol 23 (3) ◽  
pp. 82-87 ◽  
Author(s):  
Eva van Leer

Mobile tools are increasingly available to help individuals monitor their progress toward health behavior goals. Commonly known commercial products for health and fitness self-monitoring include wearable devices such as the Fitbit© and Nike + Pedometer© that work independently or in conjunction with mobile platforms (e.g., smartphones, media players) as well as web-based interfaces. These tools track and graph exercise behavior, provide motivational messages, offer health-related information, and allow users to share their accomplishments via social media. Approximately 2 million software programs or “apps” have been designed for mobile platforms (Pure Oxygen Mobile, 2013), many of which are health-related. The development of mobile health devices and applications is advancing so quickly that the Food and Drug Administration issued a Guidance statement with the purpose of defining mobile medical applications and describing a tailored approach to their regulation.


Sign in / Sign up

Export Citation Format

Share Document